Aethlon Medical announces pricing of $4.5M common stock, warrant offering

Aethlon Medical (AEMD) announced the pricing of a public offering of an aggregate of 5M shares of its common stock and warrants to purchase up to 5M shares of common stock at a combined public offering price of 90c per share and accompanying warrant. The warrants will have an exercise price of 90c per share, will be exercisable immediately upon issuance and will expire on the fifth anniversary of the original issuance date. The closing of the offering is expected to occur on or about September 5, subject to the satisfaction of customary closing conditions. Maxim Group is acting as the exclusive placement agent for the offering. The gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $4.5M. The company intends to use the net proceeds from this offering for general corporate purposes, which may include clinical trial expenses, research and development expenses, capital expenditures, and working capital.